Welcome to the 6th IPF Summit
With two approved therapeutics and the field working to develop the next generation of IPF drugs, the opportunity to become the undisputed, most effective, and disease-modifying agent on the market has never been greater.
Packed with 4 days of insightful content, the IPF Summit is back in Boston to help you delve into the persistent translational and clinical challenges in the space.
This industry’s undisputed forum will unite 150+ industry giants and pioneering academics in-person including Boehringer Ingelheim, Genentech, Novartis, AbbVie, Gilead, Fernando Martinez, Naftali Kaminski, Toby Maher, and many more. Join them to gain end-to-end insights to empower you with the knowledge you need for your 2022/2023 IPF research and drug development goals.
Organizations across autoimmunity, regenerative medicine, and inflammation are turning towards IPF as a strategic opportunity. Attend this dynamic meeting filled with formal presentations, interactive workshops, panel discussions, and organized networking to fast track your understanding, strategize success, and advance the IPF drug development frontier.
To learn more about the 2022 agenda and expert speaker faculty: